BCMA chimeric antigen receptors and uses thereof
US11952428B2 · kind B2 · utility
0Cited by
89References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 17, 2023 |
| Grant date | Apr 9, 2024 |
| Priority date | — |
| Expiry date | Feb 17, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for treating diseases associated with expression of BCMA. The invention also relates to chimeric antigen receptor (CAR) specific to BCMA, vectors encoding the same, and recombinant T cells comprising the BCMA CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises a BCMA binding domain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.